As Cephalon Inc.’s $397 million takeout of CIMA Laboratories Inc. enters its 12th week in a second request with the Federal Trade Commission, sources either firmly anticipated a resolution or expressed confusion about the timing.
To read the entire story, you must be logged in.
Please log in now or register with us.
